Serum Soluble IL-2 Receptors Are Elevated in Febrile Illnesses and Useful for Differentiating Clinically Similar Malignant Lymphomas from Kikuchi Disease: A Cross-Sectional Study
Open Access
- 31 May 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3248
Abstract
Background: The use of serum soluble interleukin 2 receptor (sIL-2R) for the diagnosis of febrile illnesses has not been examined. In this study, febrile patients were classified according to etiology and disease, and serum sIL-2R levels were evaluated. We determined whether serum sIL-2R is a useful marker for differentiating between malignant lymphoma (ML) and non-ML patients and between patients with ML and Kikuchi disease, which present similar clinical manifestations. Methods: This study was a cross-sectional study and included 344 patients with uncomplicated hemophagocytic syndrome, who had a fever of 38 °C or higher within 1 week of admission to our institution. Patient serum sIL-2R was measured, and the serum sIL-2R values are shown as median and IQR. Results: Serum sIL-2R increased above the upper reference limit in all disease groups with fever. The serum sIL-2R level in ML patients (n = 13) was 4760 (2120–6730) U/mL and significantly higher (p < 0.001) than the level of 998 (640–1625) U/mL in non-ML patients (n = 331). The serum sIL-2R level in ML patients (n = 13) was also significantly higher (p < 0.001) compared with that in patients with Kikuchi disease (n = 20; 705 (538–1091) U/mL). Conclusions: Serum sIL-2R tends to exceed the upper reference limit in patients with febrile illnesses. We conclude that the measurement of serum sIL-2R is useful for differentiating ML from non-ML and ML from Kikuchi disease.Keywords
Funding Information
- JSPS KAKENHI (23K06864)
This publication has 29 references indexed in Scilit:
- Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patientsAmerican Journal of Clinical Pathology, 2024
- Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with feverScientific Reports, 2023
- The IL-2 – IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptorClinical Immunology, 2020
- The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysisRenal Failure, 2020
- Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping reviewAnnals of Hematology, 2017
- Fever of Unknown Origin: A Clinical ApproachThe American Journal of Medicine, 2015
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Fever of Unknown Origin in Older AdultsClinics in Geriatric Medicine, 2007
- Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritisJournal of Clinical Immunology, 1988
- Elevated Levels of Soluble Interleukin-2 Receptors in Multiple SclerosisNew England Journal of Medicine, 1988